CT HB05394

Licensed pharmacists would be required to dispense FDA-approved opioid antagonists (such as naloxone) without a patient-specific prescription to any individual, including family members or others capable of assisting someone at risk of overdose

Eliminates the existing medical protocol standing order procedure under section 20-633d of Connecticut general statutes

All pharmacies in the state must maintain a continuous and sufficient supply of FDA-approved opioid antagonists to meet community needs

All pharmacists must complete the training and certification program approved by the Department of Consumer Protection

Health care providers and nonprofit organizations serving people affected by drug abuse and addiction would be expressly permitted to acquire, store, and administer opioid antagonists, with civil liability immunity provided to persons or entities who administer them